NCAM1-TTC12-ANKK1-DRD2 gene cluster and the clinical and genetic heterogeneity of adults with ADHD

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 6, 2015, Pages 433-444

  Mota, Nina R ^a,b   Rovaris, Diego L ^a,b   Kappel, Djenifer B ^a,b   Picon, Felipe A ^b   Vitola, Eduardo S ^b   Salgado, Carlos A I ^b   Karam, Rafael G ^b   Rohde, Luis A ^a,b   Grevet, Eugenio H ^a,b   Bau, Claiton H D ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Attention deficit hyperactivity disorder; Comorbidity; Dopamine receptor; Personality

Indexed keywords

ADULT; ANKK1 GENE; ARTICLE; ATTENTION DEFICIT DISORDER; AVOIDANCE BEHAVIOR; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DRD2 GENE; FEMALE; GENE; GENE CLUSTER; GENERALIZED ANXIETY DISORDER; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NCAM1 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPERAMENT; TTC12 GENE;

EID: 84939563078     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32317     Document Type: Article

References (94)

1. Acosta MT, Vélez JI, Bustamante ML, Balog JZ, Arcos-Burgos M, Muenke M. 2011. A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome. Transl Psychiatry 1:e17.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th edition. Washington DC: American Psychiatric Association. p 886p.
3. Anckarsäter H, Stahlberg O, Larson T, Hakansson C, Jutblad SB, Niklasson L, Nydén A, Wentz E, Westergren S, Cloninger CR, Gillberg C, Rastam M. 2006. The impact of ADHD and autism spectrum disorders on temperament, character, and personality development. Am J Psychiatry 163:1239-1244.
4. Aonurm- Helm A, Jürgenson M, Zharkovsky T, Sonn K, Berezin V, Bock E, Zharkovsky A. 2008. Depression-like behaviour in neural cell adhesion molecule (NCAM)- deficient mice and its reversal by an NCAM-derived peptide, FGL. Eur J Neurosci 28:1618-1628.
5. Arcos- Burgos M, Vélez JI, Solomon BD, Muenke M. 2012. A common genetic network underlies substance use disorders and disruptive or externalizing disorders. Hum Genet 131:917- 929.
6. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
7. Bidwell LC, McGeary JE, Gray JC, Palmer RH, Knopik VS, MacKillop J. 2014. NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence [epub ahead of print] doi: 10.1007/s00213-014-3748-2
8. Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M. 2006. Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry 67:524-540.
9. Bontempi S, Fiorentini C, Busi C, Guerra N, Spano P, Missale C. 2007. Identification and characterization of two nuclear factor-kappaB sites in the regulatory region of the dopamine D2 receptor. Endocrinology 148:2563-2570.
10. Borroto-Escuela DO, Van Craenenbroeck K, Romero-Fernandez W, Guidolin D, Woods AS, Rivera A, Haegeman G, Agnati LF, Tarakanov AO, Fuxe K. 2011. Dopamine D2 and D4 receptor heteromerization and its allosteric receptor-receptor interactions. Biochem Biophys Res Commun 404:928-934.
11. Chang Z, Lichtenstein P, Asherson PJ, Larsson H. 2013. Developmental twin study of attention problems: High heritabilities throughout development. JAMA Psychiatry 70:311-318.
12. Cloninger CR, Svrakic DM, Przybeck TR. 1993. A psychobiological model of temperament and character. Arch Gen Psychiatry 50:975-990.
13. Cosgrove VE, Rhee SH, Gelhorn HL, Boeldt D, Corley RC, Ehringer MA, Young SE, Hewitt JK. 2011. Structure and etiology of co-occurring internalizing and externalizing disorders in adolescents. J Abnorm Child Psychol 39:109-123.
14. de Cerqueira CCS, Polina ER, Contini V, Marques FZC, Grevet EH, Salgado CAI, da Silva POG, Picon FA, Belmonte-de-Abreu P, Bau CHD. 2011. ADRA2A polymorphisms and ADHD in adults: Possible mediating effect of personality. Psychiatry Res 186:345-350.
15. Diana M. 2011. The dopamine hypothesis of drug addiction and its potential therapeutic value. Front Psychiatry 2:64.
16. Downey KK, Stelson FW, Pomerleau OF, Giordani B. 1997. Adult attention deficit hyperactivity disorder: Psychological test profiles in a clinical population. J Nerv Ment Dis 185:32-38.
17. Ducci F, Kaakinen M, Pouta A, Hartikainen AL, Veijola J, Isohanni M, Charoen P, Coin L, Hoggart C, Ekelund J, Peltonen L, Freimer N, Elliott P, Schumann G, Järvelin MR. 2011. TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood. Biol Psychiatry 69:650-660.
18. Dunlop BW, Nemeroff CB. 2007. The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64:327-337.
19. Etter JF. 2010. Smoking and cloninger's temperament and character inventory. Nicotine Tob Res 12:919-926.
20. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention- deficit/hyperactivity disorder. Biol Psychiatry 57:1313-1323.
21. Faraone SV, Kunwar A, Adamson J, Biederman J. 2009. Personality traits among ADHD adults: Implications of late-onset and subthreshold diagnoses. Psychol Med 39:685-693.
22. Fiorentini C, Guerra N, Facchetti M, Finardi A, Tiberio L, Schiaffonati L, Spano P, Missale C. 2002. Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB. Mol Endocrinol 16:353-366.
23. Frank Y, Pergolizzi RG, Perilla MJ. 2004. Dopamine D4 receptor gene and attention deficit hyperactivity disorder. Pediatr Neurol 31:345-348.
24. Frank MJ, Hutchison K. 2009. Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms. Neuroscience 164:131-140.
25. Fuentes D, Tavares H, Camargo CHP, Gorenstein C. 1999. Inventário de Temperamento e Caráter de Cloninger-validação da versão em Português. Revista de Psiquiatria Clínica 26:363-376.
26. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-2229.
27. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ, Kranzler HR, Farrer L. 2006. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Gen 15:3498-3507.
28. Genro JP, Kieling C, Rohde LA, Hutz MH. 2010. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses. Expert Rev Neurother 10:587-601.
29. Gizer IR, Ficks C, Waldman ID. 2009. Candidate gene studies of ADHD: A meta-analytic review. Hum Genet 126:51-90.
30. Gonzalez S, Rangel- Barajas C, Peper M, Lorenzo R, Moreno E, Ciruela F, Borycz J, Ortiz J, Lluis C, Franco R, McCormick PJ, Volkow ND, Rubinstein M, Floran B, Ferré S. 2012. Dopamine D4 receptor, but not the ADHD-associated D4. 7 variant, forms functional heteromers with the dopamine D2S receptor in the brain. Mol Psychiatry 17:650-662.
31. Hayden EP, Klein DN, Dougherty LR, Olino TM, Laptook RS, Dyson MW, Bufferd SJ, Durbin CE, Sheikh HI, Singh SM. 2010. The dopamine D2 receptor gene and depressive and anxious symptoms in childhood: Associations and evidence for gene-environment correlation and gene-environment interaction. Psychiat Gen 20:304-310.
32. Hink LK, Rhee SH, Corley RP, Cosgrove VE, Hewitt JK, Schulz-Heik RJ, Lahey BB, Waldman ID. 2013. Personality dimensions as common and broadband-specific features for internalizing and externalizing disorders. J Abnorm Child Psychol 41:939-957.
33. Hirvonen M, Laakso A, Någren K, Rinne JO, Pohjalainen T, Hietala J. 2004. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 9:1060-1061.
34. Hirvonen M, Laakso A, Någren K, Rinne JO, Pohjalainen T, Hietala J. 2005. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 10:889. (Corrigendum).
35. Hirvonen MM, Laakso A, Någren K, Rinne JO, Pohjalainen T, Hietala J. 2009. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 63:907-912.
36. Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N, Li MD. 2009. Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology 34:319-330.
37. Huuhka K, Anttila S, Huuhka M, Hietala J, Huhtala H, Mononen N, Lehtimäki T, Leinonen E. 2008. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy. Neurosci Lett 448:79-83.
38. Jacob CP, Romanos J, Dempfle A, Heine M, Windemuth-Kieselbach C, Kruse A, Reif A, Walitza S, Romanos M, Strobel A, Brocke B, Schäfer H, Schmidtke A, Böning J, Lesch KP. 2007. Co-morbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci 257:309-317.
39. Jacob C, Gross-Lesch S, Jans T, Geissler J, Reif A, Dempfle A, Lesch KP. 2014. Internalizing and externalizing behavior in adult ADHD. Atten Defic Hyperact Disord 6:101-110.
40. Jain M, Velez JI, Acosta MT, Palacio LG, Balog J, Roessler E, Pineda D, Londoño AC, Palacio JD, Arbelaez A, Lopera F, Elia J, Hakonarson H, Seitz C, Freitag CM, Palmason H, Meyer J, Romanos M, Walitza S, Hemminger U, Warnke A, Romanos J, Renner T, Jacob C, Lesch KP, Swanson J, Castellanos FX, Bailey-Wilson JE, Arcos-Burgos M, Muenke M. 2012. A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD. Mol psychiatry 17:741-747.
41. Jönsson EG, Nothen MM, Grünhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. 1999. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 4:290-296.
42. Jürgenson M, Aonurm- Helm A, Zharkovsky A. 2012. Partial reduction in neural cell adhesion molecule (NCAM) in heterozygous mice induces depression-related behaviour without cognitive impairment. Brain Res 1447:106-118.
43. Kendler KS, Gardner CO, Gatz M, Pedersen NL. 2007. The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med 37:453-462.
44. Kendler KS, Prescott CA, Myers J, Neale MC. 2003. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry 60:929-937.
45. Kendler KS, Aggen SH, Knudsen GP, Røysamb E, Neale MC, Reichborn- Kjennerud T. 2011. The structure of genetic and environmental risk factors for syndromal and subsyndromal common DSM-IV axis I and all axis II disorders. Am J Psychiatry 168:29-39.
46. Kendler KS, Myers J. 2013. The boundaries of the internalizing and externalizing genetic spectra in men and women. Psychol Med 44:647-655.
47. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM. 2006. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry 163:716-723.
48. Kessler RC, Ormel J, Petukhova M, McLaughlin KA, Green JG, Russo LJ, Stein DJ, Zaslavsky AM, Aguilar-Gaxiola S, Alonso J, Andrade L, Benjet C, de Girolamo G, de Graaf R, Demyttenaere K, Fayyad J, Haro JM, Hu Cy, Karam A, Lee S, Lepine JP, Matchsinger H, Mihaescu-Pintia C, Posada- Villa J, Sagar R, Ustün TB. 2011a. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry 68:90-100.
49. Kessler RC, Petukhova M, Zaslavsky AM. 2011b. The role of latent internalizing and externalizing predispositions in accounting for the development of comorbidity among common mental disorders. Curr Opin Psychiatry 24:307-312.
50. Klimek V, Schenck JE, Han H, Stockmeier CA, Ordway GA. 2002. Dopaminergic abnormalities in amygdaloid nuclei in major depression: A postmortem study. Biol Psychiatry 52:740-748.
51. Lawford BR, Young R, Noble EP, Kann B, Ritchie T. 2006. The D2 dopamine receptor (DRD2) gene is associated with co-morbid depression, anxiety and social dysfunction in untreated veterans with post-traumatic stress disorder. Eur Psychiatry 21:180-185.
52. Le Foll B, Gallo A, Le Strat Y, Lu L, Gorwood P. 2009. Genetics of dopamine receptors and drug addiction: A comprehensive review. Behav Pharmacol 20:1-17.
53. Li M, Ma J, Beuten J. 2004. Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin Genet 66:382-392.
54. Melis M, Spiga S, Diana M. 2005. The dopamine hypothesis of drug addiction: Hypodopaminergic state. Int Rev Neurobiol 63:101-154.
55. Miettunen J, Raevuori A. 2012. A meta-analysis of temperament in axis I psychiatric disorders. Compr Psychiat 53:152-166.
56. Milivojevic D, Milovanovic SD, Jovanovic M, Svrakic DM, Svrakic NM, Svrakic SM, Cloninger CR. 2012. Temperament and character modify risk of drug addiction and influence choice of drugs. Am J Addict 21:462- 467.
57. Mota NR, Araujo-Jnr EV, Paixão-Côrtes VR, Bortolini MC, Bau CH. 2012. Linking dopamine neurotransmission and neurogenesis: The evolutionary history of the NTAD (NCAM1-TTC12- ANKK1-DRD2) gene cluster. Genet Mol Biol 35:912-918.
58. Mota NR, Rovaris DL, Bertuzzi GP, Contini V, Vitola ES, Grevet EH, Roman T, Callegari-Jacques SM, Hutz MH, Bau CH. 2013a. DRD2/DRD4 heteromerization may influence genetic susceptibility to alcohol dependence. Mol Psychiatry 18:401-402.
59. Mota NR, Bau CH, Banaschewski T, Buitelaar JK, Ebstein RP, Franke B, Gill M, Kuntsi J, Manor I, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant JA, Sonuga-Barke EJ, Steinhausen HC, Faraone SV, Asherson P. 2013b. Association between DRD2/DRD4 interaction and conduct disorder: A potential developmental pathway to alcohol dependence. Am J Med Genet Part B Neuropsychiatr Genet 162B:546-549.
60. Müller DJ, Chiesa A, Mandelli L, De Luca V, De Ronchi D, Jain U, Serretti A, Kennedy JL. 2010. Correlation of a set of gene variants, life events and personality features on adult ADHD severity. J Psychiatr Res 44:598-604.
61. Munafò M, Clark T, Johnstone E, Murphy M, Walton R. 2004. The genetic basis for smoking behavior: A systematic review and meta-analysis. Nicotine Tob Res 6:583-597.
62. Munafò MR, Matheson IJ, Flint J. 2007. Association of the DRD2 gene Taq1A polymorphism and alcoholism: A meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 12:454-461.
63. Munafò MR, Timpson NJ, David SP, Ebrahim S, Lawlor DA. 2009. Association of the DRD2 gene Taq1A polymorphism and smoking behavior: A meta-analysis and new data. Nicotine Tob Res 11:64- 76.
64. Nelson EC, Lynskey MT, Heath AC, Wray N, Agrawal A, Shand FL, Henders AK, Wallace L, Todorov AA, Schrage AJ, Saccone NL, Madden PA, Degenhardt L, Martin NG, Montgomery GW. 2013. ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: Importance of considering drug exposure. JAMA Psychiatry 70:325-333.
65. Neville MJ, Johnstone EC, Walton RT. 2004. Identification and characterization of ANK K1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23:540-545.
66. 2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48:648-654.
67. Nyman ES, Loukola A, Varilo T, Taanila A, Hurtig T, Moilanen I, Loo S, McGough JJ, Järvelin MR, Smalley SL, Nelson SF, Peltonen L. 2012. Sex-specific influence of DRD2 on ADHD-type temperament in a large population-based birth cohort. Psychiatr Genet 22:197-201.
68. Ongur D, Farabaugh A, Iosifescu DV, Perlis R, Fava M. 2005. Tridimensional personality questionnaire factors in major depressive disorder: Relationship to anxiety disorder comorbidity and age of onset. Psychother Psychosom 74:173-178.
69. Pohjalainen T, Rinne JO, Någren K, Lehikoinen P, Anttila K, Syvälahti EK, Hietala J. 1998. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3:256-260.
70. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. 2007. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 164:942-948.
71. Polina ER, Rovaris DL, de Azeredo LA, Mota NR, Vitola ES, Silva KL, Guimarães-da- Silva PO, Picon FA, Belmonte-de-Abreu P, Rohde LA, Grevet EH, Bau CH. 2014. ADHD diagnosis may influence the association between polymorphisms in nicotinic acetylcholine receptor genes and tobacco smoking. Neuromolecular Med 16:389-397.
72. Ponce G, Hoenicka J, Jiménez-Arriero MA, Rodríguez-Jiménez R, Aragues M, Martin-Sune N, Huertas E, Palomo T. 2008. DRD2 and ANKK1 genotype in alcohol- dependent patients with psychopathic traits: Association and interaction study. Br J Psychiatry 193:121-125.
73. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de Bakker PIW, Daly MJ, Sham PC. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575.
74. Purper- Ouakil D, Cortese S, Wohl M, Aubron V, Orejarena S, Michel G, Asch M, Mouren MC, Gorwood P. 2010. Temperament and character dimensions associated with clinical characteristics and treatment outcome in attention-deficit/hyperactivity disorder boys. Compr Psychiat 51:286-292.
75. Roetker NS, Yonker JA, Lee C, Chang V, Basson JJ, Roan CL, Hauser TS, Hauser RM, Atwood CS. 2012. Multigene interactions and the prediction of depression in the Wisconsin Longitudinal Study. BMJ Open 2: e000944.
76. Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511:421-427.
77. Simon V, Czobor P, Bálint S, Mészáros A, Bitter I, . 2009. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 194:204-211.
78. Smith L, Watson M, Gates S, Ball D, Foxcroft D. 2008. Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: A HuGE gene- disease association review. Am J Epidemiol 167:125-138.
79. Stork O, Welzl H, Wotjak CT, Hoyer D, Delling M, Cremer H, Schachner M. 1999. Anxiety and increased 5-HT1A receptor response in NCAM null mutant mice. J Neurobiol 40:343-355.
80. Swanson JM. 1992. School-based assessments and interventions for ADD students. Irvine, CA: KC Publishing. 184p.
81. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa PD. 2007. Etiologic subtypes of attention-deficit/hyperactivity disorder: Brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 17:39-59.
82. Teh LK, Izuddin AF, Fazleen HMH, Zakaria ZA, Salleh MZ. 2012. Tridimensional personalities and polymorphism of dopamine D2 receptor among heroin addicts. Biol Res Nurs 14:188-196.
83. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA. 1997. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7:479-484.
84. Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, Kato T. 2008. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neurosci Res 60:184-191.
85. Tripp G, Wickens JR. 2009. Neurobiology of ADHD. Neuropharmacology 57:579-589.
86. Varea E, Guirado R, Gilabert-Juan J, Martí U, Castillo-Gómez E, Blasco-Ibáñez JM, Crespo C, Nácher J. 2012. Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients. J Psychiat Res 46:189-197.
87. Walmod PS, Kolkova K, Berezin V, Bock E. 2004. Zippers make signals: NCAM-mediated molecular interactions and signal transduction. Neurochem Res 29:2015-2035.
88. Wang F, Simen A, Arias A, Lu QW, Zhang H. 2013. A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Hum Genet 132:347-358.
89. Wu J, Xiao H, Sun H, Zou L, Zhu LQ. 2012. Role of dopamine receptors in ADHD: A systematic meta-analysis. Mol Neurobiol 45:605-620.
90. Xiao MF, Xu JC, Tereshchenko Y, Novak D, Schachner M, Kleene R. 2009. Neural cell adhesion molecule modulates dopaminergic signaling and behavior by regulating dopamine D2 receptor internalization. J Neurosci 29:14752-14763.
91. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J. 2007. Association of haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Gen 16:2844-2853.
92. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J. 2008. Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. Alcohol Clin Exp Res 32:2117-2127.
93. Young SE, Stallings MC, Corley RP, Krauter KS, Hewitt JK. 2000. Genetic and environmental influences on behavioral disinhibition. Am J Med Genet 96:684-695.
94. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee ML, Xiao T, Papp A, Wang D, Sadee W. 2007. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 104(51):20552-20557.